Calcium channel blockers exist in short- and long-acting forms. Short-acting medications yield faster results than their long-acting counterparts. Amlodipine, Diltiazem, Felodipine, Isradipine, and Nicardipine are calcium channel blockers used to treat coronary artery disease, angina, arrhythmias, and conditions like Raynaud's disease.
The global market for calcium channel blocker drugs is predicted to experience growth due to the rising prevalence of hypertension. Hypertension is a leading cause of premature death globally, affecting a significant number of adults, including a large population in the U.S., where millions of individuals require medication and lifestyle changes to manage the condition.
In 2022, the estimated value of the global market for Calcium Channel Blocker Drugs is US$ 14,285.3 million, with a projected compound annual growth rate (CAGR) of 5.2% from 2022 to 2030.
Top Companies in the Calcium Channel Blocker Drugs Industry:
1. Bausch Health
Bausch Health was established in 1959 and is headquartered in Laval, Canada. It has operations in more than 90 countries and is engaged in various industries, including biotechnology, healthcare, medical, and pharmaceuticals.
2. Mylan N.V.
Mylan N.V. was established in 1961 and is headquartered in Canonsburg, Pennsylvania, U.S. It has operations in 165 countries and is engaged in various industries, including biotechnology, healthcare, life science, and pharmaceuticals.
3. Teva Pharmaceutical Industries Ltd.
Teva Pharmaceutical Industries Ltd. was established in 1944 and is headquartered in Tel Aviv, Israel. It has operations in 60 countries and is engaged in various industries, including biopharma, healthcare, medical, and pharmaceuticals.
4. GlaxoSmithKline Plc
GlaxoSmithKline Plc was established in 2000 and is headquartered in Brentford, United Kingdom. It has operations in more than 100 countries and is engaged in various industries, including biotechnology, healthcare, and pharmaceuticals.
5. Novartis AG
Novartis AG was established in 1996 and is headquartered in Basel, Switzerland. It has operations in 140 countries and is engaged in various industries, including biotechnology, healthcare, medical, and pharmaceutical.
6. Zydus Cadila
Zydus Cadila Healthcare Ltd., Inc., was established in 1952 and is headquartered in Ahmedabad, Gujarat, India. It has operations in 50 countries and is engaged in developing and manufacturing an extensive range of pharmaceuticals as well as diagnostics, herbal products, skincare products, and other OTC products. In 2019, Zydus Cadila received final approval from the USFDA to market betamethasone dipropionate cream (0.05%), a generic version of Diprolene® AF, and generic amlodipine and atorvastatin tablets (Caduet®).
7. Pfizer Inc.
Pfizer Inc. was established in 1849 and is headquartered in New York, U.S. It has operations in 181 countries and is engaged in various industries, including biotechnology, healthcare, medical, and pharmaceuticals.
8. Sun Pharmaceutical Industries Ltd.
Sun Pharmaceutical Industries Ltd. was established in 1983 and is headquartered in Goregaon, Mumbai. It has operations in more than 100 countries and is engaged in manufacturing and selling pharmaceutical formulations and active pharmaceutical ingredients.
Definition: A calcium channel blocker is a medication that inhibits the influx of calcium ions into cells and is used to treat various cardiovascular conditions.
